Sage Journals: Discover world-class research

Open access

Review article

First published 2022

Current challenges of unresectable stage III NSCLC: are we ready to break the glass ceiling of the PACIFIC trial?

Jordi Remon, Antonin Levy, Pawan Singh [...]

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2020-4

Immunotherapy-induced severe neutropenia with neurotoxicity: A case of a 75-year-old woman with ulcerative colitis diagnosed with melanoma

Rima Patel, Lori Pai

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2019

Durvalumab for stage III non-small-cell lung cancer patients: clinical evidence and real-world experience

Angela Botticella, Laura Mezquita, Cecile Le Pechoux [...]

Therapeutic Advances in Respiratory Disease

Free access

Review article

First published 2014-9

Therapeutic vaccines as a promising treatment modality against prostate cancer: rationale and recent advances

B. Harpreet Singh, James L. Gulley

Therapeutic Advances in Vaccines and Immunotherapy

Open access

Case report

First published 2021

Achievement of long-term local control after radiation and anti-PD-1 immunotherapy in locally advanced non-small cell lung cancer

Zhao Jing, Rongjin Zhou, Ni Zhang

Sage Open Chronic Disease

Open access

Review article

First published 2021-08-28

First-Line Immunotherapy Combinations in Advanced Renal Cell Carcinoma: A Rapid Review and Meta-Analysis

Jason Shpilsky, Paul J. Catalano, David F. McDermott

Kidney Cancer

Retricted access

Case report

First published 2017-12

Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors

Belal Firwana, Rahul Ravilla, Mihir Raval [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2018

Durvalumab in NSCLC: latest evidence and clinical potential

Nerea Muñoz-Unceta, Isabel Burgueño, Elizabeth Jiménez [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2018

Immunotherapy in non-metastatic non-small cell lung cancer: Can the benefits of stage IV therapy be translated into earlier stages?

Griet Deslypere, Dorothée Gullentops, Els Wauters [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2022-10

Neoadjuvant or adjuvant immunotherapy in bladder cancer: biological opportunity or clinical utility?

Fausto Petrelli, Gianluca Perego, Ivano Vavassori [...]

Tumori Journal

Search results